Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic malignant syndrome.

J L Levenson

    The American Journal of Psychiatry
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Neuroleptic malignant syndrome (NMS) is a rare, severe reaction to antipsychotic drugs. This review proposes new diagnostic criteria using physical signs and lab tests for better NMS identification.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The classification of conversion disorder (functional neurologic symptom disorder) in ICD and DSM.

    Handbook of clinical neurology·2016
    Same author

    Psychosocial assessment of living organ donors: clinical and ethical considerations.

    Progress in transplantation (Aliso Viejo, Calif.)·2001
    Same author

    Update in addiction medicine.

    Annals of internal medicine·2001
    Same author

    The use of psychotropics in the medically ill.

    Current psychiatry reports·2000
    Same author

    Patients requesting psychiatric hospitalization.

    The American journal of psychiatry·2000
    Same author

    Update in psychiatry.

    Annals of internal medicine·1999
    Same journal

    2026 Annual Meeting: President-Elect Address.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: CEO and Medical Director's Address.

    The American journal of psychiatry·2026
    Same journal

    Reports to the Membership.

    The American journal of psychiatry·2026
    Same journal

    Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: Presidential Address.

    The American journal of psychiatry·2026
    Same journal

    Represcribing Previously Used Antipsychotics: Response to So.

    The American journal of psychiatry·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Neurology
    • Clinical Toxicology

    Background:

    • Neuroleptic malignant syndrome (NMS) is a rare but life-threatening adverse drug reaction associated with antipsychotic medications.
    • Early recognition and diagnosis are crucial for effective management and improved patient outcomes.

    Observation:

    • The author presents three new cases of NMS and reviews 50 previously published cases from the last five years.
    • Analysis focuses on demographic and clinical characteristics, diagnostic challenges, treatment strategies, and patient outcomes.

    Findings:

    • A critical review of existing literature and new case data was conducted.
    • Proposed new diagnostic criteria integrate key physical signs and routine laboratory findings for enhanced NMS detection.

    Related Experiment Videos

    Implications:

    • The proposed diagnostic criteria aim to improve the accuracy and timeliness of NMS diagnosis in clinical practice.
    • This work contributes to a better understanding of NMS pathophysiology and management, potentially reducing morbidity and mortality associated with antipsychotic use.